DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,167,035 | +72.4% | 91,748 | +122.1% | 0.01% | +75.0% |
| Q4 2022 | $676,973 | -10.8% | 41,304 | +0.7% | 0.00% | -20.0% |
| Q3 2022 | $759,000 | -46.7% | 41,037 | -62.1% | 0.01% | -44.4% |
| Q2 2022 | $1,423,000 | +25.7% | 108,221 | -11.4% | 0.01% | +50.0% |
| Q1 2022 | $1,132,000 | +40.8% | 122,142 | +48.4% | 0.01% | +50.0% |
| Q4 2021 | $804,000 | +9.7% | 82,326 | +281.7% | 0.00% | 0.0% |
| Q3 2021 | $733,000 | +47.5% | 21,566 | +58.9% | 0.00% | +33.3% |
| Q2 2021 | $497,000 | +262.8% | 13,573 | +343.1% | 0.00% | +200.0% |
| Q1 2021 | $137,000 | -71.8% | 3,063 | -64.0% | 0.00% | -66.7% |
| Q4 2020 | $485,000 | +11.2% | 8,500 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $436,000 | -76.8% | 8,500 | -73.0% | 0.00% | -75.0% |
| Q2 2020 | $1,883,000 | +45.1% | 31,531 | 0.0% | 0.01% | +33.3% |
| Q1 2020 | $1,298,000 | – | 31,531 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
| Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
| Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
| Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
| BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
| AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
| ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
| Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
| EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |